Europe Inhalation Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin Capsules, and Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, and Others). By Country and Growth Forecast, 2024 - 2031

The Europe Inhalation Capsules Market would witness market growth of 5.5% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Inhalation Capsules Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $83.5 Million by 2031. The UK market is exhibiting a CAGR of 4.5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 6.3% during (2024 - 2031).

Inhalation capsules, also known as dry powder inhalers (DPIs), are devices used to deliver medication directly into the lungs as a dry powder. Typically employed to treat respiratory conditions, including chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma, these capsules contain a powdered formulation of the medication. As per the World Health Organization (WHO), COPD accounted for around 6% of all deaths in 2019 and ranks as the third leading cause of death. In addition, lower respiratory infections remained the deadliest communicable disease, ranked as the 4th leading cause of death.

Additionally, the inhalation mode of drug delivery entails the patient passing their breath through the apparatus, which subsequently distributes the powdered medication into the pulmonary system for absorption into the bloodstream. The purpose of inhalation capsules is to deliver medication to the respiratory system in a targeted and efficient manner. This method provides several benefits, including improved patient compliance, a quicker onset of action, and decreased systemic side effects.

Several factors drive the growth of the inhalation capsules market in various European nations. Countries like Germany, France, Italy, and the United Kingdom are witnessing significant growth in the inhalation capsules market due to the aging population, environmental factors, and lifestyle changes contributing to the rise in respiratory disorders. Thus, all these factors will boost the regional market’s expansion in the coming years.

Free Valuable Insights: The Global Inhalation Capsules Market will Hit USD 1.4 Billion by 2031, at a CAGR of 5.9%

Based on Type, the market is segmented into Gelatin Capsules, and Hypromellose Capsules. Based on Application, the market is segmented into Asthma Treatment, COPD Management, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Cipla Limited
• Novartis AG
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Lonza Group Ltd. (Capsugel)
• Chiesi Farmaceutici S.p.A
• Vectura Group Plc (Philip Morris International, Inc.)
• Elpen S.A.
• Healthcaps India Ltd.
• Qualicaps Co., LTD. (Roquette Freres SA)

Europe Inhalation Capsules Market Report Segmentation

By Type

• Gelatin Capsules
• Hypromellose Capsules

By Application

• Asthma Treatment
• COPD Management
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Inhalation Capsules Market, by Type
1.4.2 Europe Inhalation Capsules Market, by Application
1.4.3 Europe Inhalation Capsules Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Recent Strategies Deployed in Inhalation Capsules Market

Chapter 5. Europe Inhalation Capsules Market by Type
5.1 Europe Gelatin Capsules Market by Country
5.2 Europe Hypromellose Capsules Market by Country

Chapter 6. Europe Inhalation Capsules Market by Application
6.1 Europe Asthma Treatment Market by Country
6.2 Europe COPD Management Market by Country
6.3 Europe Others Market by Country

Chapter 7. Europe Inhalation Capsules Market by Country
7.1 Germany Inhalation Capsules Market
7.1.1 Germany Inhalation Capsules Market by Type
7.1.2 Germany Inhalation Capsules Market by Application
7.2 UK Inhalation Capsules Market
7.2.1 UK Inhalation Capsules Market by Type
7.2.2 UK Inhalation Capsules Market by Application
7.3 France Inhalation Capsules Market
7.3.1 France Inhalation Capsules Market by Type
7.3.2 France Inhalation Capsules Market by Application
7.4 Russia Inhalation Capsules Market
7.4.1 Russia Inhalation Capsules Market by Type
7.4.2 Russia Inhalation Capsules Market by Application
7.5 Spain Inhalation Capsules Market
7.5.1 Spain Inhalation Capsules Market by Type
7.5.2 Spain Inhalation Capsules Market by Application
7.6 Italy Inhalation Capsules Market
7.6.1 Italy Inhalation Capsules Market by Type
7.6.2 Italy Inhalation Capsules Market by Application
7.7 Rest of Europe Inhalation Capsules Market
7.7.1 Rest of Europe Inhalation Capsules Market by Type
7.7.2 Rest of Europe Inhalation Capsules Market by Application

Chapter 8. Company Profiles
8.1 Cipla Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Novartis AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Trials and Approvals:
8.2.6 SWOT Analysis
8.3 AstraZeneca PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Trials and Approvals:
8.3.6 SWOT Analysis
8.4 Boehringer Ingelheim International GmbH
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Lonza Group Ltd. (Capsugel)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Chiesi Farmaceutici S.p.A
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.6.2.2 Product Launches and Product Expansions:
8.6.3 SWOT Analysis
8.7 Vectura Group plc (Philip Morris International, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Geographical Expansions:
8.7.6 SWOT Analysis
8.8 Elpen S.A.
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Healthcaps India Ltd.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Qualicaps Co., LTD. (Roquette Freres SA)
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 Europe Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 2 Europe Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 3 Europe Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 4 Europe Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 5 Europe Gelatin Capsules Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Gelatin Capsules Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Hypromellose Capsules Market by Country, 2020 - 2023, USD Million
TABLE 8 Europe Hypromellose Capsules Market by Country, 2024 - 2031, USD Million
TABLE 9 Europe Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 10 Europe Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 11 Europe Asthma Treatment Market by Country, 2020 - 2023, USD Million
TABLE 12 Europe Asthma Treatment Market by Country, 2024 - 2031, USD Million
TABLE 13 Europe COPD Management Market by Country, 2020 - 2023, USD Million
TABLE 14 Europe COPD Management Market by Country, 2024 - 2031, USD Million
TABLE 15 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Inhalation Capsules Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Inhalation Capsules Market by Country, 2024 - 2031, USD Million
TABLE 19 Germany Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 20 Germany Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 21 Germany Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 22 Germany Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 23 Germany Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 24 Germany Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 25 UK Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 26 UK Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 27 UK Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 28 UK Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 29 UK Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 30 UK Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 31 France Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 32 France Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 33 France Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 34 France Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 35 France Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 36 France Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 37 Russia Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 38 Russia Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 39 Russia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 40 Russia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 41 Russia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 42 Russia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 43 Spain Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 44 Spain Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 45 Spain Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 46 Spain Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 47 Spain Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 48 Spain Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 49 Italy Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 50 Italy Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 51 Italy Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 52 Italy Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 53 Italy Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 54 Italy Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 55 Rest of Europe Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 56 Rest of Europe Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 57 Rest of Europe Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 58 Rest of Europe Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 59 Rest of Europe Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 60 Rest of Europe Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 61 Key Information – Cipla Limited
TABLE 62 Key Information – Novartis AG
TABLE 63 Key Information – AstraZeneca PLC
TABLE 64 Key Information – Boehringer Ingelheim International GmbH
TABLE 65 Key Information –Lonza Group Ltd.
TABLE 66 Key Information – Chiesi Farmaceutici S.p.A
TABLE 67 Key Information – Vectura Group plc
TABLE 68 Key Information – Elpen S.A.
TABLE 69 Key Information – Healthcaps India Ltd.
TABLE 70 Key Information – Qualicaps Co., LTD.

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Inhalation Capsules Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Inhalation Capsules Market
FIG 4 Porter’s Five Forces Analysis – Inhalation capsules market
FIG 5 Europe Inhalation Capsules Market share by Type, 2023
FIG 6 Europe Inhalation Capsules Market share by Type, 2031
FIG 7 Europe Inhalation Capsules Market by Type, 2023 - 2031, USD Million
FIG 8 Europe Inhalation Capsules Market share by Application, 2023
FIG 9 Europe Inhalation Capsules Market share by Application, 2031
FIG 10 Europe Inhalation Capsules Market by Application, 2020 - 2031, USD Million
FIG 11 Europe Inhalation Capsules Market share by Country, 2023
FIG 12 Europe Inhalation Capsules Market share by Country, 2031
FIG 13 Europe Inhalation Capsules Market by Country, 2020 - 2031, USD Million
FIG 14 SWOT Analysis: Cipla Limited
FIG 15 SWOT Analysis: Novartis AG
FIG 16 Recent strategies and developments: AstraZeneca PLC
FIG 17 SWOT Analysis: AstraZeneca PLC
FIG 18 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 19 Swot Analysis: Lonza Group Ltd.
FIG 20 Recent strategies and developments: Chiesi Farmaceutici S.p.A.
FIG 21 SWOT Analysis: Chiesi Farmaceutici S.p.A
FIG 22 Recent strategies and developments: Vectura Group plc
FIG 23 Swot Analysis: Vectura Group plc
FIG 24 Swot Analysis: elpen s.a.
FIG 25 Swot Analysis: Healthcaps India Ltd.
FIG 26 Swot Analysis: Qualicaps Co., LTD.